CD5 and acute lymphoblastic leukemia: Importantly, T-ALL patients with low CD5 expression were associated with poor OS (hazard ratio (HR) = 0.367, 95% confidence interval (CI): 0.129–1.042; 5-year OS: 7.8% vs. 38.9%, P = 0.051) (Figure 2(c)).